Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm

被引:0
|
作者
Gregory B Melikyan
机构
[1] University of Maryland School of Medicine,Institute of Human Virology, Department of Microbiology and Immunology
来源
关键词
Fusion Peptide; Fusion Pore; Viral Fusion; Influenza Hemagglutinin; Viral Fusion Protein;
D O I
暂无
中图分类号
学科分类号
摘要
Enveloped viruses encode specialized fusion proteins which promote the merger of viral and cell membranes, permitting the cytosolic release of the viral cores. Understanding the molecular details of this process is essential for antiviral strategies. Recent structural studies revealed a stunning diversity of viral fusion proteins in their native state. In spite of this diversity, the post-fusion structures of these proteins share a common trimeric hairpin motif in which the amino- and carboxy-terminal hydrophobic domains are positioned at the same end of a rod-shaped molecule. The converging hairpin motif, along with biochemical and functional data, implies that disparate viral proteins promote membrane merger via a universal "cast-and-fold" mechanism. According to this model, fusion proteins first anchor themselves to the target membrane through their hydrophobic segments and then fold back, bringing the viral and cellular membranes together and forcing their merger. However, the pathways of protein refolding and the mechanism by which this refolding is coupled to membrane rearrangements are still not understood. The availability of specific inhibitors targeting distinct steps of HIV-1 entry permitted the identification of key conformational states of its envelope glycoprotein en route to fusion. These studies provided functional evidence for the direct engagement of the target membrane by HIV-1 envelope glycoprotein prior to fusion and revealed the role of partially folded pre-hairpin conformations in promoting the pore formation.
引用
收藏
相关论文
共 50 条
  • [1] Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm
    Melikyan, Gregory B.
    RETROVIROLOGY, 2008, 5 (1)
  • [2] Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion
    Rawat, Satinder Singh
    Viard, Mathias
    Gallo, Stephen A.
    Blumenthal, Robert
    Puri, Anu
    GLYCOCONJUGATE JOURNAL, 2006, 23 (3-4) : 189 - 197
  • [3] Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion
    Satinder Singh Rawat
    Mathias Viard
    Stephen A. Gallo
    Robert Blumenthal
    Anu Puri
    Glycoconjugate Journal, 2006, 23 : 189 - 197
  • [4] The HIV-1 Vif protein: a paradigm for viral: cell interactions
    Pomerantz, RJ
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (10) : 2017 - 2019
  • [5] The HIV-1 Vif protein: a paradigm for viral:cell interactions
    R. J. Pomerantz
    Cellular and Molecular Life Sciences CMLS, 2003, 60 : 2017 - 2019
  • [6] Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion
    Ou, Wu
    Silver, Jonathan
    VIROLOGY, 2006, 350 (02) : 406 - 417
  • [7] HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures
    Aksenov, M. Y.
    Aksenova, M. V.
    Mactutus, C. F.
    Booze, R. M.
    NEUROSCIENCE LETTERS, 2010, 475 (03) : 174 - 178
  • [8] Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage
    Denton, Adam R.
    Mactutus, Charles F.
    Lateef, Almeera U.
    Harrod, Steven B.
    Booze, Rosemarie M.
    JOURNAL OF NEUROVIROLOGY, 2021, 27 (03) : 403 - 421
  • [9] HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions
    Qi, Qianqian
    Wang, Qian
    Chen, Weizao
    Du, Lanying
    Dimitrov, Dimiter S.
    Lu, Lu
    Jiang, Shibo
    EMERGING MICROBES & INFECTIONS, 2017, 6 : 1 - 7
  • [10] Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage
    Adam R. Denton
    Charles F. Mactutus
    Almeera U. Lateef
    Steven B. Harrod
    Rosemarie M. Booze
    Journal of NeuroVirology, 2021, 27 : 403 - 421